Transforming growth factor b (TGFb) can act either as a tumor promoter or a tumor suppressor in a contextdependent manner. High levels of TGFb are found in prostate cancer tissues and correlate with poor patient prognosis. We recently identified a novel TGFb-regulated signaling cascade in which TGFb type I receptor (TbRI) is activated by the E3 ligase TNF-receptor-associated factor 6 (TRAF6) via the Lys63-linked polyubiquitination of TbRI. TRAF6 also contributes to activation of TNF-a-converting enzyme and presenilin-1, resulting in the proteolytic cleavage of TbRI and releasing the intracellular domain of TbRI, which is translocated to the nucleus to promote tumor invasiveness. In this report, we provide evidence that Lys178 of TbRI is polyubiquitinated by TRAF6. Moreover, our data suggest that TRAF6-mediated Lys63-linked ubiquitination of the TbRI intracellular domain is a prerequisite for TGFb regulation of mRNA for cyclin D1 (CCND1), expression, as well as for the regulation of other genes controlling the cell cycle, differentiation, and invasiveness of prostate cancer cells.
Introduction
Aggressive prostate cancer is a lethal disease due to the invasion and metastasis of disseminated cancer cells. 1 Transforming growth factor b (TGFb) plays pivotal roles in controlling cell proliferation, apoptosis, and the final fate of metazoan cells. 2, 3 In malignancies, TGFb is initially a tumor suppressor, since it inhibits cell proliferation and induces apoptosis, but at later stages of tumor progression, it is often produced at high levels by tumor and stromal cells and promotes tumor progression. 2, 3 TGFb brings together 2 pairs of TGFb type II and TGFb type I receptors (TbRI) to form a heterotetrameric complex. 4 TbRI is activated via phosphorylation of its glycine/serine-rich domain by TGFb type II receptor, thereby inducing the activation of several downstream signaling pathways. [5] [6] [7] Activated TbRI propagates signals through the receptor-associated Smads (R-SMAD; SMAD2, and SMAD3) by phosphorylation of their extreme C termini. 8, 9 Activated Smads form complexes with the co-Smad Smad4, translocating to the nucleus to regulate the transcription of certain genes. [10] [11] [12] [13] TGFb also transduces signals through non-Smad signaling pathways such as those involving extracellular signal-regulated kinase, Jun N-terminal kinases, p38 mitogen-activated protein kinases (MAPKs), and other pathways. 3, 14 Recent investigations revealed that TbRI has a consensus binding motif for the E3 ubiquitin ligase TRAF6. Activation of TRAF6 is induced by ligand-induced hetero-oligomerization of the TbR complex. Thereafter, catalytically active TRAF6 in turn catalyzes Lys63-linked polyubiquitination of TGFb activated kinase 1 (TAK1), which activates the p38 and JNK MAPK pathways, leading to apoptosis and the epithelial-mesenchymal transition (EMT). 11, 15, 16 Various post-translational modifications, such as phosphorylation, acetylation, and ubiquitination, determine the function and role of proteins and can thereby control specific cellular processes such as apoptosis, cell-cycle progression, and gene regulation. 17 Ubiquitination is one such post-translational modification in which ubiquitin is covalently bound to an acceptor lysine of the target protein. 18 Covalent attachment of Lys48-linked polyubiquitin to target proteins promotes their proteasomal degradation, whereas Lys63-linked polyubiquitination modulates the activity or trafficking of the substrate protein. [19] [20] [21] [22] We recently reported a mechanism whereby TGFb promotes the invasiveness of cancer cells. [23] [24] [25] TGFb induces the activation of TRAF6, which ubiquitinates TbRI in a Lys63-dependent manner and promotes proteolytic cleavage of the receptor by TNF a-converting enzyme (TACE) and presenilin-1, resulting in the release of the intracellular domain (ICD) of TbRI. [23] [24] [25] The TbRI ICD is then translocated to the nucleus, where it associates with the transcriptional co-activator p300 and promotes tumor-cell invasion by inducing the expression of genes encoding TbRI, Snail1, and matrix metallopeptidase 2 (MMP2). 23, 24, 26 In the present study, we identified the acceptor lysine in TbRI that is ubiquitinated by TRAF6, and determined the biological significance of this ubiquitination.
Results
Lys178 is the acceptor lysine for Lys63-linked polyubiquitination of TbRI Previously, we reported that TbRI is polyubiquitinated in a Lys63-dependent manner by TRAF6. 23 We observed that Lys178 is the only lysine near the transmembrane region of TbRI in close proximity to the TRAF6 consensus binding site, suggesting that it could be the acceptor lysine for polyubiquitination. 15 To investigate whether Lys178 is an acceptor lysine, we created a point mutant in the wild-type, constitutively active TbRI (c.a.TbRI) in which Lys178 was mutated to arginine.
We performed in vivo ubiquitination assays in PC-3U cells transiently transfected with C-terminally hemagglutinin (HA)-tagged wild-type TbRI (HA-TbRI) or with the HA-tagged K178R mutant TbRI (HA-K178R); these cells were or were not exposed to TGFb. HA-TbRI and HA-K178R proteins were immunoprecipitated with anti-HA antibodies and subjected to immunoblotting with antiserum against Lys63-linked polyubiquitin. Stimulation of cells with TGFb resulted in Lys63-linked polyubiquitination in cells transfected with HA-TbRI, but not in cells transfected with HA-K178R (Fig. 1A) .
To further validate that Lys178 is the acceptor lysine for polyubiquitination by TRAF6, we performed in vitro ubiquitination assays. Recombinant glutathione S-transferase (GST) -TbRI or GST-tagged mutant TbRI (GST-K178R) was incubated in the presence or absence of GST-TRAF6 for 1 h at 37 C, and then subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) followed by immunoblotting against polyubiquitin. GST-TbRI was ubiquitinated by TRAF6, but GST-K178R was not (Fig. 1B) . Reaction mixtures without E2 or without E1 were used as negative controls (Fig. 1B) . No TGFbinduced ICD formation was observed for HA-K178R, whereas an ICD was formed from HA-TbRI (Fig. 1C) . The kinase activity of HA-TbRI K178R was intact in PC-3U cells, as it was found to phosphorylate Smad2, whereas in cells transfected with HA-K178R, we detected reduced phosphorylation of p38 (Fig. 1C) .
Next, we repeated the experiments in LNCaP cells, which harbor a non-functional TbRI. 27 In LNCaP cells transfected with wild-type TbRI, TGFb stimulated phosphorylation of both Smad2 and p38, but in cells transfected with the K178R mutant of TbRI, TGFb stimulated phosphorylation only of Smad2 and not of p38 (Fig. 1D) .
Mutation of the acceptor lysine in TbRI inhibits nuclear translocation
To investigate the importance of Lys63-linked polyubiquitination of TbRI for its subcellular localization, we performed a nuclear fractionation assay of cells transfected with the wild-type TbRI or K178R mutant of TbRI, Stimulation of cells with TGFb resulted in nuclear translocation of TbRI-ICD in cells transfected with HA-TbRI, but not in cells transfected with HA-K178R (Fig. 1E) . Next we validated this finding by using immunofluorescence and confocal microscopy. We fused green fluorescent protein (GFP) with the C-termini of wild-type (TbRI-GFP) and mutant (GFP-K178R) TbRI. PC-3U cells were transfected with GFP-TbRI or GFP-K178R and immunofluorescence staining was performed to visualize the receptors with confocal microscopy. Only GFP-TbRI translocated to the nucleus upon TGFb stimulation; nuclear translocation of GFP-K178R was inhibited (Fig. 1F) . Similar results were obtained in PC-3U cells transfected with molecules tagged with HA (Fig. 1G ).
TGFb induces proximity between TbRI and Lys63-polyubiquitin chains
We used the proximity ligation assay (PLA) to investigate the proximity of TbRI to Lys63-polyubiquitin chains. PC-3U cells ectopically expressing HA-TbRI or HA-K178R were treated or not treated with TGFb, fixed, blocked, and probed with anti-HA antibody (rabbit) and anti-Lys63-polyubiquitin antibody (mouse). TGFb stimulation led to a significant increase in signal in PC-3U cells transfected with HA-TbRI but not with HA-K178R; very little signal was detected in the latter ( Fig. 2A) . Taken together, these observations indicate that TGFb enhanced the proximity between wild-type TbRI and Lys63-polyubiquitin chains, an effect that was not detected for the K178R mutant of TbRI, supporting the hypothesis that Lys178 is the acceptor lysine for Lys63-linked polyubiquitination of TbRI.
We performed immunoprecipitation experiments to investigate whether the point mutation in the K178R mutant TbRI affected its interaction with TRAF6. Importantly, both wild-type and mutant TbRI interacted with TRAF6 (Fig. 2B) . Immunofluorescence experiments also confirmed the association of HATbRI and HA-K178R with the E3 ligase TRAF6 (Fig. 2C) . In addition, PLAs of PC-3U cells transiently transfected with HATbRI or HA-K178R showed that both HA-TbRI and HA-K178R associated with TRAF6 in a TGFb-dependent manner (Fig. 2D) .
From these observations, we conclude that K178 in TbRI is the acceptor lysine for Lys63-linked polyubiquitination catalyzed by TRAF6 in response to TGFb stimulation. Furthermore, this event is crucial for TGFb-and TRAF6-induced cleavage of TbRI, as well as for nuclear translocation of the TbRI ICD.
TbRI ubiquitination induces gene expression that regulates the cell cycle and cell invasion
We previously reported that TGFb-induced nuclear localization of the TbRI ICD leads to increased expression of the pro-invasive genes SNAI1 (also known as Snail1), matrix metallopeptidase 2 (MMP2), and TbRI. 23, 24 To further explore the set of genes regulated by TGFb-induced and TRAF6-mediated polyubiquitination of TbRI, we performed quantitative reverse transcription polymerase chain reaction (qRT-PCR) to analyze the mRNA expression of Vimentin, Twist1, N-cadherin, p73, cyclin D1 (CCND1), and Plasminogen activator inhibitor-1 (PAI1) (Fig. 3) . We found that TGFb promotes the expression of Vimentin, Twist1, N-cadherin, and cyclin D1 (CCND1) more efficiently in PC-3U cells transfected with HA-TbRI than in cells transfected with HA-K178R (Fig. 3 ). In contrast, TGFb induction of the expression of the tumor suppressor gene p73 was higher in HA-K178R-transfected cells than in HA-TbRItransfected cells (Fig. 3) . As expected, both wild-type and mutant TbRI induced the classical TGFb target gene PAI1 (Fig. 3) , demonstrating that the K178R mutation did not interfere with the kinase activity of TbRI and Smad signaling, consistent with data in Figures 1C and D .
To further understand the role of TRAF6 in TGFb signaling in prostate cancer cells, PC-3U cells were transfected with control or TRAF6-specific siRNA, and RNA microarray analysis was performed to identify TGFb-dependent genes regulated by TRAF6 (Fig. 4) . These genes include the invasive marker Snail1 and cell cycle regulators like cyclin B1 (CCNB1), Cyclin-A1 (CCNA1), and CCND1. We previously identified Snail1, TGFbRI, and Jagged1 (Jag1) as targets of the TGFb-and TRAF6-induced Lys63-linked polyubiquitination of TbRI. 23, 24 We report here that TGFb exposure increased the mRNA expression of the G0/G1 cell-cycle inducer CCND1 (encoding cyclin D1) in a manner dependent on TRAF6-induced Lys63-linked polyubiquitination of TbRI at K178 (Fig. 3) . In this context, to further understand the role of cyclin D1, we investigated the cell-cycle profile of cells transfected with HA-TbRI or HA-K178R. Wild type-and mutant-transfected cell populations were chosen and gated via fluorescence-activated cell sorting; cells positive for pyronin y (a RNA stain) and Hoechst (a DNA stain) were further assessed (Fig. 5A, B) . Interestingly, we found that TGFb exposure for 48 h significantly enhanced the transition of cells from early G0 to G1 in HA-TbRI transfected cells, compared to HA-K178R transfected cells (Fig. 5B,  Fig. S1A ).
Next, cells positive for HA-TbRI-allophycocyanin or HA-K178R-allophycocyanin and Hoechst were selected and cell cycle profiles were analyzed. TGFb treatment for 48 h promoted the cell cycle progression by increased number of cell in G1 in HATbRI-transfected cells, compared to HA-K178R-transfected cells. But, then there was also a reduction of cell cycle progression from G1 to S phase in HA-TbRI-transfected cells, while this response was less efficient in HA-K178R-transfected cells (Fig. 5C, D Fig. S1B ). This difference could be linked to that HA-K178R-transfected cells without TGFb treatment, were found to be moderately apoptotic (Fig. S1B) , suggesting that the TbRI-TRAF6 pathway also provides pro-survival signals. Statistical analysis of 5 independent experiments revealed a significance difference in mRNA and DNA content during G1 and S between HA-TbRI-transfected cells (48 h TGFb exposure) and HA-K178R-transfected cells (48 h TGFb exposure) (Fig. S1B) . Taken together, these results suggest that cyclin D1, a critical moderator of the transition of cells from G0 to early G1, is poorly regulated in cells transfected with HA-K178R.
TGFb-induced nuclear localization of the TbRI-ICD is linked to the invasion behavior of cancer cells. 23, 24 We therefore investigated the invasive capability of PC-3U cells expressing HA-TbRI or HA-K178R. Only cells expressing HA-TbRI exhibited invasive properties (Fig. 6A) and similar results were obtained from invasion assays with LNCaP cells (Fig. 6B) . From these data, we conclude that TGFb-induced invasiveness of cancer cells is linked to TRAF6-dependent Lys63-linked polyubiquitination of Lys178 of TbRI.
Discussion
The crucial role of TGFb signaling during EMT and cancer progression is well established. 2, 3 TGFb transduces signals through Smad and non-Smad signaling pathways. The cellular effects regulated through canonical Smad signaling have been thoroughly elucidated, while the biological significance of nonSmad signaling pathways induced by TGFb still is gradually being unraveled. 7, 28 In order to enhance or specify TGFb signaling, TRAF family members (TRAF6 and, recently, TRAF4), have been shown to play important roles in activating the TAK1-p38 MAPK pathway and in positively regulating both Smaddependent and Smad-independent TGFb signaling. 
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In vitro ubiquitination assays were performed with recombinant GST-TbRI or GST-K178R in the presence or absence of GST-TRAF6; samples were subjected to SDS-PAGE, followed by IB with anti-polyubiquitin (Ub) antibodies. Only GST-TbRI, and not GST-K178R, was ubiquitinated in the presence of TRAF6. Reaction mixtures without E2 or without E1 were used as negative controls. (C) A portion of the total cell lysate was subjected to IB against HA, p-p38, and p-SMAD2 with specific antisera. The filters were then reblotted with antisera against p38 and SMAD2. Actin was used as a control for equal protein loading onto the gel. (TbRI-FL: Full length TGFb Receptor I, TbRI-ICD: TGFb Receptor I intracellular domain) (D) LNCaP cells transiently transfected with HA-TbRI or HA-K178R were exposed to TGFb as indicated. Total cell lysates were subjected to IB with antisera against p-p38 and p-SMAD2. The filter was then reblotted with antisera against p38 and SMAD2; IB with HA antiserum was used as a control for transfection. (E) PC-3U cell lysates were transfected with HA-TbRI or HA-K178R and exposed to TGFb as indicated; cytoplasmic and nuclear fractions were subjected to SDS-PAGE, then IB with HA antibody. Membranes were re-blotted with b-tubulin and lamin A as controls for the cytoplasmic and nuclear fractions, respectively. Our previous research identified a non-Smad signaling cascade in which TRAF6 plays a central role. 15 TGFb utilizes TRAF6 to cause Lys63-linked polyubiquitination of the TbRI-ICD, which is associated with proteolytic cleavage by ADAM17/TACE and subsequent intramembranous proteolysis of TbRI by presenilin-1, a catalytic core component of the g-secretase complex. 23, 24 The nuclear TbRI ICD binds the transcriptional co-activator p300 and drives the expression of proinvasive genes like Snail1 and MMP2 to promote oncogenic phenotypes such as invasion. 23 In the current study, we identified Lys178 as the acceptor lysine for TRAF6-induced TbRI ubiquitination (Fig. 1) . We found that mutagenesis of this lysine to arginine inhibited TGFb-dependent ubiquitination both in vivo and in vitro. Importantly, TRAF6 associated with both TbRI and the K178R Figure 2 . TRAF6 associates with both wild-type and mutant TbRI. (A) PC-3U cells transiently transfected with wild-type HA-TbRI or mutant HA-K178R was treated as indicated. Left, ubiquitinated HA-TbRI was visualized by staining cells with proximity probes directed against Lys63-polyubiquitin and HA (red), followed by ligation and rolling circle amplification of the oligonucleotides. Cell nuclei were stained with 2-(4-amidinophenyl)-1H-indole-6-carboxamidine (DAPI; blue). Right, PLA signal was quantified with the Duolink ImageTool. Data are from 3-5 independent experiments; *P < 0.05. Scale bars, 20 mm. (B) PC-3U cells transfected with HA-TbRI or HA-K178R were treated as indicated, and cell lysates were immunoprecipitated (IP) with anti-HA antibodies and subjected to immunoblotting with antibodies against TRAF6. Light chain-specific secondary antiserum was used to avoid cross-reaction with the IgG heavy chain. The filter was reprobed with HA antiserum as a control. (C) PC-3U cells were transfected with HA-TbRI or HA-K178R. Red, HA; green, TRAF6; blue, nuclei (DAPI). (D) Top, PC-3U cells were transiently transfected with HA-TbRI or HA-K178R and exposed to TGFb as indicated. The association of TbRI with TRAF6 was visualized by staining cells with proximity probes against TRAF6 and HA (red), followed by ligation and rolling circle amplification. Blue, nuclei. Scale bars, 20 mm. Bottom, quantification of PLA signal from 3-5 independent experiments; *P < 0.05. mutant of TbRI, but Lys63-polyubiquitination occurred only in cells overexpressing wild-type TbRI. Moreover, immunofluorescence assays indicated that the mutant did not enter the nucleus of HA-K178R-transfected or GFP-K178R-transfected cells, suggesting that Lys63-polyubiquitination is a prerequisite for the cleavage and nuclear trafficking of TbRI, consistent with our previous findings. 23, 24 Moreover, our data show that TbRI ubiquitination enhances the expression of certain target genes, like Vimentin, twist family bHLH transcription factor 1 (Twist1), and N-cadherin, implicated in EMT and invasion.
Transitions between the phases of the cell cycle are tightly regulated by the expression of cyclins, which enable cell-cycle progression. 31 Most importantly, early G1 phase progression is governed by cyclin D1; in contrast, in late G1, cyclin E play a pivotal role in allowing the cell to pass the restriction point and enter S phase. 32 Interestingly, we found in this study that mRNA , have recently reported that p21 depletion from senescent cells leads to decreased levels of cyclin D1 and cyclin E, while the cellcycle progressed from S phase into mitosis but resulted in cell death which occurred during mitotic arrest or after mitotic slippage. 36, 37 We have previously shown that TRAF6 in a noncanonical, Smad-independent pathway, regulates both the expression of c-Jun, a transcription factor implicated in stress responses, and p21, a classical target gene for TGFb and p53, in cells treated with TGFb. 25 As cyclin D1 has been reported to contain binding sites for AP-1 transcription factor (heterodimers of the Fos and Jun families), 38, 39 c-Jun may regulate both the levels of both cyclin D1 and the pro-invasive protein Snail. 40, 41 Here, we found that TRAF6, via its Lys63-linked polyubiquitination of K178 in TbRI, regulates both EMT-associated genes as well as cyclin D1 expression which might reflect that the cancer cells also become senescent due to conflicting signaling inputs. This could further explain the aggressiveness of these cancer cells (Fig. 5, Fig. S1 ). Interference with this pathway could influence the tendency for senescence or result in changes of the metabolic status of cells which also is changed during TGFb-induced EMT. 42 Further studies are required to elucidate whether the pathway unraveled in this study, also controls the metabolic status of cancer cells.
In conclusion, although Smad signaling pathways are important, non-Smad signaling pathways also play critical roles in regulating cellular homeostasis in epithelial cells and in cancer initiation, progression, and invasion. 23, 24 In particular, the E3 ligase TRAF6 plays a key role in TGFb-induced tumor progression due to its catalytic activity, resulting in liberation of the TbRI-ICD. Here we have demonstrated that TRAF6 promotes Lys63-linked polyubiquitination at K178 of TbRI, leading to its nuclear translocation and subsequent regulation of genes implicated in tumor invasion and progression. The identification of TRAF6 as a key component of the TGFb-induced invasive program may be an important step in the development of future biomarkers and drugs against aggressive prostate cancer. 
Materials and Methods

Cell culture
In this study, we used 2 human prostate cancer cell lines: PC-3U (derived from PC3 cells) 43 and LNCaP (from ATCC). These cell lines were cultured in Roswell Park Memorial Institute (RPMI)-1640 medium supplemented with 10% fetal bovine serum, 1% glutamine, and 1% penicillin/streptomycin (all from Sigma). PC-3U and LNCaP cells were starved in medium containing 1% fetal bovine serum for 18 h after transient transfection using Fugene6 (Promega). Ten nanograms per milliliter of TGFb1 (R&D Systems) were used to stimulate cells.
Antibodies and reagents
Antibodies against the following epitopes were used for immunoblotting, immunoprecipitation, or immunofluorescence: HA (Y11) and ubiquitin (P4D1), from Santa Cruz Biotechnology; p-Smad2, generated at the Ludwig Institute for Cancer Research, Uppsala, Sweden; and Smad2, p-Smad2, p38, p-p38, and HA, from Cell Signaling. Lys63 polyubiquitin mouse monoclonal antibody was obtained from Enzo Life Sciences. An antibody against TRAF6 was obtained from Zymed Laboratories. Horseradish peroxidase-conjugated secondary anti-rabbit and anti-mouse antibodies were purchased from GE Healthcare and Dako, respectively. Light chain-specific anti-rabbit and antimouse antibodies were obtained from Jackson Laboratory. Secondary donkey anti-rabbit Alexa Fluor 555 antibodies and goat anti-mouse Alexa Fluor 488 antibodies (Invitrogen) were used for immunofluorescence. Tris-buffered saline and phosphatebuffered saline (PBS) were purchased from Medicago. Protein-G Sepharose was obtained from GE Healthcare, LumiLight Western Blotting Substrate and Pefabloc were purchased from Roche Life Science, and PageRuler Prestained Protein Ladder was obtained from Fermentas. 
Immunoblotting and immunoprecipitation
Prior to lysis, cells were washed with ice-cold PBS and lysed in ice-cold RIPA buffer (150 mM NaCl, 50 mM Tris [pH 8.0], 1% Triton X-100, 10% (v/v) glycerol, 1 mM aprotinin, 1 mM Pefabloc, 1 mM sodium orthovanadate). The BCA Protein Assay Kit (Nordic Biolabs) was used to measure protein concentration. Equal amounts of proteins were used for immunoblotting or immunoprecipitation, and SDS-PAGE was conducted using 10%, 12%, or 4-12% bis-Tris polyacrylamide gels using MOPS buffer (Invitrogen). Proteins were transferred using an iBlot machine (Invitrogen).
Plasmids C-terminally HA-tagged c.a.TbRI (HA-TbRI) was a kind gift from P. ten Dijke and is referred to as "wildtype" in comparison to the K187R mutant of TbRI. The expression vector for HA-K178R was generated by PCR and site-directed mutagenesis; the mutation was confirmed via sequencing. GFP-TbRI was constructed in-house, as previously described. 23 Using this plasmid, we created a C-terminally GFP-tagged K178R mutant (GFP-K178R) via site-directed mutagenesis. Expression vectors for GST fusion proteins encoding the complete cytoplasmic parts (amino acid residues 148-503) of c.a. TbRI (T204D) and GST-K178R were also used.
Immunofluorescence PC-3U cells were washed with PBS and fixed with 4% formaldehyde. Cells were permeabilized with 2% Triton X-100 and blocked in 5% bovine serum albumin. After incubation with primary and secondary antibodies, Fluoromount with 2-(4-amidinophenyl)-1H-indole-6-carboxamidine was used to stain cell nuclei. Confocal images of mounted cells were taken using a Zeiss 710 Meta (Carl Zeiss Microimaging, Inc.) with a digital camera (RET-EXi-F-M-12-C). Images were analyzed with Zen software.
qRT-PCR An RNeasy Mini Kit (Qiagen) was used to isolate total RNA, and the Thermoscript RT-PCR System (Invitrogen) was used to prepare double-stranded cDNA. qRT-PCR was performed using Power SYBR Green PCR Masterrmix (Applied Biosystems) on an Applied Biosystems 7900HT Fast Real-time PCR system. The following primers were used for qRT-PCR (Table 1) .
In vivo ubiquitination assays
After stimulation with TGFb, PC-3U cells were washed once in ice-cold PBS, then scraped into 1 mL ice-cold PBS and centrifuged at 2,000 rpm for 5 min. Non-covalent protein interactions were dissociated via treatment in 1% sodium dodecyl sulfate for 10 min at 95 C. Samples were diluted in ice-cold PBS (1:10) containing 0.5% NP40, 1 mM aprotinin, and 1 mM Pefabloc. Samples were centrifuged at 13,000 rpm for 10 min, and then the supernatants were subjected to immunoprecipitation followed by immunoblotting.
In vitro ubiquitination assay Reaction mixtures containing 2 mM E1, 2.5 mM E2 Ubc13-Uev1, purified GST-TbRI, or GST-K178R (~0.1 mg) were incubated at 37 C for 1 h in the presence or absence of recombinant GST-TRAF6 (»0.1 mg) in 20 mM Tris [pH 7.4], 50 mM NaCl (Sigma), 10 mM MgCl 2 (Sigma), 10 mM dithiothreitol (Sigma), 10 mM ATP (Sigma), 2.5 mM ubiquitin, and 100 mM MG132 (Sigma). Reactions were stopped by adding non-reducing sample buffer, and the samples were subjected to SDS-PAGE and immunoblotted with antisera against TbRI-(V22) (Santa Cruz Biotechnology), TRAF6 (Invitrogen), and K63-polyubiquitin (Enzo Life Sciences). Reaction mixtures with or without E1 and with or without E2 were used as controls.
Nuclear fractionation assay
Cells grown in 10-cm dishes were transfected with HA-TbRI or HA-K178R, then starved and stimulated with TGFb for the indicated times. Subcellular fractionation was performed as previously described. Protein concentration was measured using BCA Protein Assay Kit, and equal amounts of protein were used for immunoblotting. Antibodies against lamin A (Cell Signaling) and b-tubulin (Cell Signaling) were used as loading controls for the nuclear and cytoplasmic fractions, respectively.
In situ PLA Transiently transfected PC-3U cells were treated with TGFb for 30 min or left untreated, fixed, blocked, and then probed with the primary antibodies indicated. These antibodies were raised in different species and directed toward the intracellular C-terminally HA-tagged domains of TbRI, Lys63-polyubiquitin, or TRAF6. Cells were blocked and incubated with 2 sets of primary antibodies; in addition, the samples were incubated with 2 PLA probes, which were later ligated and amplified. Thereafter, the slides were mounted with Duolink Mounting Medium (Sigma) and evaluated via confocal microscopy (Carl Zeiss). The amplified PLA signals were analyzed using Blob-Finder image analysis software (version 2.5), which was developed by the Center for Image Analysis, Uppsala University, Sweden.
Microarray analysis
Cells were seeded and transfected with control siRNA or TRAF6 siRNA and left untreated or stimulated with TGFb for 30 min, 2 h, or 12 h. Total RNA was isolated from PC-3U cells transfected with HA-TbRI or HA-K178R using the RNeasy Mini Kit. We used the service at Uppsala Array Platform (Uppsala University) for microarray analysis. RNA quality was confirmed by bioanalyser prior to Affymetrix gene expression analysis. We also used bioinformatics support from Uppsala Array Platform. Flow cytometry PC-3U cells transfected with HA-TbRI or HA-K178R were starved and stimulated with TGFb for 48 h. Cells were harvested, fixed, permeabilized, stained with anti-HA primary antibody (Santa Cruz Biotechnology), and incubated with secondary anti-rabbit allophycocyanin antibody (Jackson Laboratories). Later, cells were stained with pyronin Y (Sigma-Aldrich) to label RNA and Hoechst (Sigma-Aldrich) to label DNA. Fluorescenceactivated cell sorting was performed at the Umea Immunology Center on a FACS LSR II (BD Biosciences), and data were analyzed using BD Biosciences software.
Invasion assays
Invasion assays were performed using the CytoSelect TM Cell Invasion Assay (Cell Biolabs, Inc.). The collagen membrane layers of the cell-culture inserts were rehydrated in 300 mL serum-free RPMI-1640, and 2 £ 10 6 cells were seeded on the upper area of the membrane in serum-free RPMI-1640 with or without TGFb. The lower chamber was filled with 500 mL RPMI supplemented with 10% fetal bovine serum. Non-invasive cells were removed from the upper chamber and cells that had transversed the membrane were stained with cell-staining solution (Cell Biolabs, Inc.). A Leica DMR light microscope was used to image stained invasive cells. Colorimetric quantification was performed by measuring optical density at 560 nm.
Statistical analysis
Mann-Whitney 2-tailed tests were used to calculate p values. Analyses were performed using SPSS Statistics (IBM SPSS Statistics 20 software). Values are expressed as mean § standard deviation of 3 or more independent experiments performed in triplicate, unless otherwise indicated. P values <0.05 were considered statistically significant.
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